Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, not yet licensed by the MHRA or EMA in the UK
Before starting any treatment option , our providers evaluate your body mass index (BMI) and relevant medical conditions to determine if you are a good candidate
Tools like bioimpedance scans offered at TrimBody M.D
No fad diets
For example, IGF-1 stimulates glucose transport in osteoblasts the cells that form bone tissue
Retatrutide has been well-tolerated in research, with no significant side effects reported
US$ 24.47
US$ 21.00
US$ 27.15
US$ 25.37
US$ 21.03
